Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 18/20 | 1.00 |
| ▸ | PDE3B | Q13370 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12671632 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL17974376 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL12634565 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL17325408 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL12634582 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL18737202 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL24467522 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL738 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL21470181 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A | |
| SCHEMBL21498373 | 1.00 | STING1 (1.00) | STING1PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8724 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680215-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING ADVERSE EFFECTS OF THERAPIES | MDX Management LLC (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4593847-A1 | INHIBITION OF GENOTOXIC STRESS TO IMPROVE T CELL ENGINEERING | GENENTECH, INC. (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2025076210-A1 | CHLAMYDIA VACCINE COMPOSITIONS | VAXCYTE, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| US-20250099622-A1 | COMPOSITIONS AND METHODS FOR EXPRESSING THERAPEUTICS | Avirmax Biopharma Inc. | 2025-03-27 | — | — | US | claimed |
| WO-2025015182-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNITY | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) | 2025-01-16 | — | — | WO | claimed |
| EP-4490300-A1 | COMPOSITIONS AND METHODS FOR EXPRESSING THERAPEUTICS | Avirmax Biopharma Inc. (US) | 2025-01-15 | — | — | EP | claimed |
| CN-119256089-A | Compositions and methods for expressing therapeutic agents | 阿维麦克思生物制药公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119074933-A | Novel strategy for delivering cGAMP molecules | 海南大学 | 2024-12-06 | — | — | CN | claimed |
| WO-2024196822-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING ADVERSE EFFECTS OF THERAPIES | MDX MANAGEMENT LLC (US) | 2024-09-26 | — | — | WO | claimed |
| EP-4433599-A1 | SPHERICAL NUCLEIC ACIDS FOR CGAS-STING AND STAT3 PATHWAY MODULATION FOR THE IMMUNOTHERAPEUTIC TREATMENT OF CANCER | Northwestern University (US) | 2024-09-25 | — | — | EP | claimed |
| WO-1994022855-A1 | NITROGEN-CONTAINING FUSED-HETEROCYCLE COMPOUNDS | EISAI CO., LTD. (JP) | 1994-10-13 | — | — | WO | claimed |
| WO-1994013278-A1 | METHODS FOR TREATMENT WITH DIMERCAPTOSUCCINIC ACID (DMSA) | CEDARS-SINAI MEDICAL CENTER (US) | 1994-06-23 | — | — | WO | claimed |
| EP-0535216-A1 | DNA ENCODING MAMMALIAN PHOSPHODIESTERASES | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1993-04-07 | — | — | EP | claimed |
| WO-1992018541-A1 | DNA ENCODING MAMMALIAN PHOSPHODIESTERASES | THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0493444-A1 | BLOOD-BRAIN BARRIER MODEL | ATHENA NEUROSCIENCES, INC. (US) | 1992-07-08 | — | — | EP | claimed |
| EP-0234854-B1 | USE OF PHOSPHODIESTERASE INHIBITORS AND CYCLIC NUCLEOTIDE ANALOGUES FOR THE MANUFACTURE OF A MEDICAMENT FOR STIMULATING TEAR SECRETION | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1991-05-08 | — | — | EP | claimed |
| WO-1991005038-A1 | BLOOD-BRAIN BARRIER MODEL | ATHENA NEUROSCIENCES, INC. (US) | 1991-04-18 | — | — | WO | claimed |
| EP-0406210-A2 | Ophthalmic composition | WASHINGTON UNIVERSITY (US) | 1991-01-02 | — | — | EP | claimed |
| US-4885301-A | Purinone derivatives which have bronchodilator, vasodilator and anti-allergic activities | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-12-05 | — | — | US | claimed |
| EP-0234854-A2 | Use of phosphodiesterase inhibitors and cyclic nucleotide analogues for the manufacture of a medicament for stimulating tear secretion | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1987-09-02 | — | — | EP | claimed |